Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 2
1954 1
1956 4
1957 1
1958 3
1959 4
1960 1
1961 8
1962 4
1963 5
1964 6
1965 6
1966 8
1967 13
1968 13
1969 10
1970 12
1971 14
1972 11
1973 19
1974 11
1975 5
1976 16
1977 11
1978 12
1979 12
1980 13
1981 13
1982 17
1983 20
1984 19
1985 15
1986 30
1987 28
1988 34
1989 21
1990 34
1991 30
1992 40
1993 49
1994 43
1995 46
1996 45
1997 46
1998 62
1999 48
2000 59
2001 80
2002 73
2003 66
2004 70
2005 69
2006 70
2007 84
2008 73
2009 68
2010 71
2011 78
2012 82
2013 91
2014 79
2015 109
2016 98
2017 104
2018 102
2019 92
2020 134
2021 97
Text availability
Article attribute
Article type
Publication date

Search Results

2,525 results
Results by year
Filters applied: . Clear all
Page 1
Gastric adenocarcinoma.
Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S. Ajani JA, et al. Among authors: sano t. Nat Rev Dis Primers. 2017 Jun 1;3:17036. doi: 10.1038/nrdp.2017.36. Nat Rev Dis Primers. 2017. PMID: 28569272 Review.
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial.
Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, Nagao N, Takahashi M, Takagane A, Watanabe T, Kaji M, Okitsu H, Nomura T, Matsui T, Yoshikawa T, Matsuyama J, Yamada M, Ito S, Takeuchi M, Fujii M. Yoshida K, et al. Among authors: sano t. J Clin Oncol. 2019 May 20;37(15):1296-1304. doi: 10.1200/JCO.18.01138. Epub 2019 Mar 29. J Clin Oncol. 2019. PMID: 30925125 Free PMC article. Clinical Trial.
Gastric cancer: Asia and the world.
Sano T. Sano T. Gastric Cancer. 2017 Mar;20(Suppl 1):1-2. doi: 10.1007/s10120-017-0694-9. Gastric Cancer. 2017. PMID: 28144923 No abstract available.
Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501).
Terashima M, Iwasaki Y, Mizusawa J, Katayama H, Nakamura K, Katai H, Yoshikawa T, Ito Y, Kaji M, Kimura Y, Hirao M, Yamada M, Kurita A, Takagi M, Boku N, Sano T, Sasako M; Stomach Cancer Study Group, Japan Clinical Oncology Group. Terashima M, et al. Among authors: sano t. Gastric Cancer. 2019 Sep;22(5):1044-1052. doi: 10.1007/s10120-019-00941-z. Epub 2019 Mar 2. Gastric Cancer. 2019. PMID: 30827001 Clinical Trial.
Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial.
Iwasaki Y, Terashima M, Mizusawa J, Katayama H, Nakamura K, Katai H, Yoshikawa T, Ito S, Kaji M, Kimura Y, Hirao M, Yamada M, Kurita A, Takagi M, Lee SW, Takagane A, Yabusaki H, Hihara J, Boku N, Sano T, Sasako M. Iwasaki Y, et al. Among authors: sano t. Gastric Cancer. 2021 Mar;24(2):492-502. doi: 10.1007/s10120-020-01136-7. Epub 2020 Nov 16. Gastric Cancer. 2021. PMID: 33200303
2,525 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page